XML 37 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Operations (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Product sales $ 310,867 $ 1,198,230 $ 703,113 $ 3,336,506
Cost of product sales 100,134 504,988 295,925 1,483,862
Gross profit from product sales 210,733 693,242 407,188 1,852,644
Retained royalties 5,955 4,322 70,337 20,244
Gains on sale of rental assets       34,728
Investment income     1,496  
Other income 16,634 9,486 39,327 30,625
Total other revenue 22,589 13,808 111,160 85,597
Selling expenses 125,633 219,029 306,889 416,123
Personnel and consulting expenses 277,493 430,778 1,111,058 1,204,288
General and administrative expenses 393,023 601,055 1,369,128 2,114,537
Interest expense 18,628 9,002 40,923 28,992
Unrealized loss (gain) on derivative instrument 15,434 (15,149) 24,317 17,361
Total Expenses 830,211 1,244,715 2,852,315 3,781,301
Income (loss) before income taxes (596,889) (537,665) (2,333,967) (1,843,060)
Net income (loss) $ (596,889) $ (537,665) $ (2,333,967) $ (1,843,060)
Basic income (loss) per share $ (0.04) $ (0.04) $ (0.16) $ (0.13)
Basic weighted average number of common shares outstanding: 15,184,765 14,255,351 14,930,809 13,994,740
Diluted income (loss) per share $ (0.04) $ (0.04) $ (0.16) $ (0.13)
Diluted weighted average number of common shares outstanding: 15,184,765 14,255,351 14,930,809 13,994,740